| Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377) |
|---|
| 06/15/2006 | US20060128572 Phosphoric esters of polyisobutene-substituted aromatic hydroxy compounds |
| 06/15/2006 | US20060127990 4'-thionucleotide |
| 06/15/2006 | US20060127775 Antistatic agents; electron activable precursors to a redox couple; reversible switchable systems; imidazole/imidazolium, phosphine/phosphonium systems; photoelectric cells; high ionic conductivity solar cells; heat resistance; solvent solubility; colorless; corrosion resistance |
| 06/15/2006 | CA2589688A1 Compounds analogous to lipid membranes in archaebacteria and liposomal compositions including said compounds |
| 06/14/2006 | EP1669398A1 Reactive flame retardant and flame-retardant processed resin obtained with the same |
| 06/14/2006 | EP1668028A1 Antisense compound and method for selectively killing activated t cells |
| 06/14/2006 | EP1667955A2 Cycloalkylidene compounds as modulators of the estrogen receptor |
| 06/14/2006 | EP1667954A1 Bipolar trans carotenoid salts and their uses |
| 06/14/2006 | EP1495129A4 Hybrid phosphoinositide phospholipids: compositions and uses |
| 06/14/2006 | EP1438076B1 Radiopharmaceutical agent for the treatment of early stage cancer |
| 06/14/2006 | EP1263771B1 Chemoselective ligation by use of a phosphine |
| 06/14/2006 | EP1226147B1 Phosphite |
| 06/14/2006 | EP1163553B1 Oxime derivatives and the use thereof as photoinitiators |
| 06/14/2006 | DE19933932B4 Verfahren zur Herstellung von DOP und danach hergestelltes DOP mit reduziertem OPP-Gehalt Process for the preparation of DOP and then made DOP with reduced OPP content |
| 06/14/2006 | CN1788011A Process for production of phosphine-borane complexes |
| 06/14/2006 | CN1787817A 免疫抑制剂化合物及组合物 Immunosuppressant compounds and compositions |
| 06/14/2006 | CN1786007A Preparation method of adenine derivative |
| 06/14/2006 | CN1786006A Preparation method of substituted diaryl phosphate |
| 06/14/2006 | CN1786005A Hetero poly phosphorus vanadate antitumour medicine and its synthesis method |
| 06/14/2006 | CN1785524A Room temperature ionic liquid and its preparation method |
| 06/14/2006 | CN1259326C Process for preparing trialkyl group VA metal compound |
| 06/14/2006 | CN1259325C Diphosphate, preparation and uses of its pharmaceutical preparations |
| 06/13/2006 | US7060855 Asymmetric phosphinoselenoic chloride and method for producing the same |
| 06/13/2006 | US7060697 Immunosuppressant compounds and compositions |
| 06/13/2006 | US7060290 Phosphocholine linked prodrug derivatives |
| 06/13/2006 | US7060250 Chelate compounds |
| 06/13/2006 | US7060248 Chelate compounds; diagnosis of disease; detection of conjestive heart failurel |
| 06/13/2006 | US7060243 Tellurium-containing nanocrystalline materials |
| 06/08/2006 | WO2006060692A2 Supported group-4, group-5, and group-6 metal clusters, preparation of the material and use of the material as a catalyst |
| 06/08/2006 | WO2006060573A1 Non-scorch flame retarded polyurethane foam |
| 06/08/2006 | WO2006058737A1 Compounds for organic electronic devices |
| 06/08/2006 | WO2006037869A3 Fluorophosphonocinnamic compounds, synthesis and uses for treating disorders caused by oxidative stress |
| 06/08/2006 | WO2006031938A3 Oxidation catalyst and its use for catalyzing liquid phase oxidation reactions |
| 06/08/2006 | US20060122435 With CO in the presence of a source of hydroxyl groups (water or an alcohol) and a catalyst obtained by combining a Group VIII metal or a compound thereof and a bidentate phosphine, e.g., tri(dibenzylideneacetone)di-palladium |
| 06/08/2006 | US20060122408 Photogenerated reagents |
| 06/08/2006 | US20060122404 Novel compounds comprising a thiocarbonyl-sulfanyl group, which can be used for the radical synthesis of-alpha-perfluoroalkylamines |
| 06/08/2006 | US20060122401 Process for manufacture of fosinopril sodium |
| 06/08/2006 | US20060122395 Industrial process for the synthesis of 2-substituted 1-(hydroxy-ethylidene)-1,1-bisphosfi- conic acids of high purity and the salts thereof |
| 06/08/2006 | US20060122391 treatment of RNA viral infections such as HCV, HBV, small pox, Ebola, polio, West Nile, Coxsackie A and B, Rhino, and Echo viral infection; viricides |
| 06/08/2006 | US20060122383 Antiviral methods employing double esters of 2', 3'-dideoxy-3'-fluoroguanosine |
| 06/08/2006 | US20060122203 2-Hydroxymethylcyclopropylidenemethylpurines and - pyrimidines as antiviral agents |
| 06/08/2006 | US20060122155 Carbacyclic phosphatidic acid derivative |
| 06/08/2006 | US20060122154 1-(2-(Hydroxymethyl)-5-thiolanyl)pyrrolo[2.3d]pyrimidine derivatives or their phosphates: 4-amino-7-(2-C-methyl-4-thio- beta -D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine; hepatitis C virus |
| 06/08/2006 | US20060122153 Antineoplastic ether lipid compounds with modifications at the sn-2 carbon |
| 06/08/2006 | US20060120957 Radioactive transition metal-imido hetero-diphosphine complexes, their preparation and radiopharmaceutical compositions thereof |
| 06/08/2006 | DE102004057760A1 Methode zur Synthese von langkettigen Phosphonsäurederivaten und Thiolderivaten Method for the synthesis of long-chain phosphonic acid and thiol derivatives |
| 06/08/2006 | DE102004056822A1 Neue Wirkstoffe zu Therapie, Diagnostik und Prophylaxe der Makula-Degeneration New drugs for the therapy, diagnosis and prevention of macular degeneration |
| 06/08/2006 | DE10081928B4 6-O-Acetylmorphin (6MAM)-Analoge Verbindungen, welche zur Verwendung in Immuntests geeignet sind, hiergegen gewonnene Antikörper, deren Herstellung sowie Reagentien und Reagenssysteme, die diese umfassen 6-O-acetylmorphine (6MAM) analogs compounds which are suitable for use in immunoassays, antibody obtained against this, their preparation as well as reagents and reagent systems which comprise these |
| 06/08/2006 | CA2586114A1 Process for {3-[2(r)-[(1r)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3(s)-(4-fluorophenyl)morpholin-4-yl]methyl]-5-oxo-4,5-dihydro-[1,2,4]-triazol-1-yl}phosphonic acid |
| 06/07/2006 | EP1666486A1 Compound modified with glycerol derivative |
| 06/07/2006 | EP1666484A1 Ascorbic acid derivatives and skin-whitening cosmetics |
| 06/07/2006 | EP1664069A1 Mitoquinone derivatives used as mitochondrially targeted antioxidants |
| 06/07/2006 | EP1664068A2 Process for the preparation of n-phosphono-methylglycine and derivatives thereof |
| 06/07/2006 | EP1664046A1 Aza-quinolinol phosphonate integrase inhibitor compounds |
| 06/07/2006 | EP1663987A1 Ophthalmic compositions for treating ocular hypertension |
| 06/07/2006 | EP1663254A2 Anti-inflamatory phosphonate conjugates |
| 06/07/2006 | EP1663210A1 N3 alkylated benzimidazole derivatives as mek inhibitors |
| 06/07/2006 | EP1663157A2 Stabilized formulations of phosphatidylserine |
| 06/07/2006 | EP1539772A4 Process of making phosphordiamidite compounds |
| 06/07/2006 | EP1534718A4 Chemical synthesis of reagents for peptide coupling |
| 06/07/2006 | EP0934065B1 Novel cryptophycin derivatives as anti-neoplastic agents |
| 06/07/2006 | CN1784414A Phospholane salts and their use in enantioselective hydrogenation |
| 06/07/2006 | CN1784413A Esters of phosphorus-oxygen acids, these esters comprising alkoxy groups, and their use as corrosion inhibitors and flameproofing agents |
| 06/07/2006 | CN1784367A Use of phosphorus-oxygen acid esters containing alkoxy groups as corrosion inhibitors for reinforced concrete |
| 06/07/2006 | CN1781976A Flame-retardant processed product |
| 06/07/2006 | CN1781919A Method for producing by stereospecific hydration tetrahydropterins and optically pure derivatives, in particular tetrahydrofolic acid and its optically pure derivatives |
| 06/07/2006 | CN1258522C Multi-dentate phosphite ligands, catalytic compositions containing such ligands and catalytic processes utilizing such catalytic compositions |
| 06/07/2006 | CN1258520C Phosphoric-amino acids salts and additive composition containing the same and use in ruminant feed |
| 06/06/2006 | US7057082 Process for the telomerization of a conjugated diene, catalyst and bidentate ligand useful therein |
| 06/06/2006 | US7057065 Process for production of vinylphosphonic acids and silyl esters thereof |
| 06/06/2006 | US7057062 Dissolving a crude phosphorodiamidite in an apolar organic solvent, contacting the non-polar organic solvent with a polar phase comprising a polar organic solvent to remove impurities; removing the nonpolar solvent; antisense agents |
| 06/06/2006 | US7057061 Chiral monophosphorus compounds |
| 06/06/2006 | US7057059 Tumor-inhibiting platinum (II) oxalate complexes |
| 06/06/2006 | US7056902 4-dedimethylamino tetracycline compounds |
| 06/06/2006 | US7056854 Carbonylation using catalyst containing platinum and diphsophine compound |
| 06/06/2006 | CA2259399C Metallocene compounds |
| 06/06/2006 | CA2231295C Lower-ash lubricating oil having ultra-neutral zinc dialkyldithiophosphates |
| 06/06/2006 | CA2136903C Acetic acid derivatives |
| 06/01/2006 | WO2006058184A2 Preparation of tridentate phosphines, method of forming aldehyde hydrogenation catalysts using them and process for aldehyde hydrogenation |
| 06/01/2006 | WO2006057272A1 Novel fluorine-containing polyether phosphonate compound and method for producing same |
| 06/01/2006 | WO2006056541A1 Process for preparing acylphosphanes and derivatives thereof |
| 06/01/2006 | WO2006056182A1 Novel active substances for treating, diagnosing and preventing macular degeneration |
| 06/01/2006 | WO2006004935A3 Pegylated cardiolipin analogs, methods of synthesis, and uses thereof |
| 06/01/2006 | US20060116526 Process for producing pentaerythritol diphosphonates |
| 06/01/2006 | US20060116491 polymerization catalyst for the polymerization of olefins; molecular weight control of polyethylene, ethylene-hexene copolymer; preparation of 3-2-pyridyl-1-methylethyl)indenyl)chromium dichloride |
| 06/01/2006 | US20060116454 Stable thermally coaguable polyurethane dispersions |
| 06/01/2006 | US20060116400 Oxazolidinone and/or isoxazoline derivatives as antibacterial agents |
| 06/01/2006 | US20060116358 Delivering modified inositol hexaphosphate (IHP); enhance the ability of mammalian red blood cells to deliver oxygen, by delivering IHP to the cytoplasm of the red blood cells; cardiovascular and respiratory disorders |
| 06/01/2006 | US20060116357 Aurora kinases inhibitors; antiproliferative agents; specially for solid and haematological tumors; 2-[[3-({4-[(5-{2-[(3-fluorophenyl)amino]-2-oxoethyl}-1H-pyrazol-3-yl)amino]-quinazolin-7-yl}oxy)propyl](ethyl)amino]ethyl dihydrogen phosphate |
| 06/01/2006 | US20060116356 Phosphonate analogs of HIV integrase inhibitor compounds |
| 06/01/2006 | US20060116354 Antineoplastic ether lipid compounds with modifications at the sn-3 carbon |
| 06/01/2006 | US20060115815 Method and compositions for identifying anti-hiv therapeutic compounds |
| 06/01/2006 | US20060115426 Methods of detecting breast cancer, brain cancer, and pancreatic cancer |
| 06/01/2006 | DE102004057171A1 Verwendung von Trimethylarsin als Verbindung mit organoleptischen Eigenschaften Using trimethyl as a compound with organoleptic properties |
| 05/31/2006 | EP1661903A1 Novel transition metal complex and process for producing optically active alcohol with the complex |
| 05/31/2006 | EP1661900A1 Olefin polymerization cocatalysts derived from group-15 cationic compounds and processes using them |
| 05/31/2006 | EP1660473A2 Xanthones, thioxanthones and acridinones as dna-pk inhibitors |
| 05/31/2006 | EP1660449A1 Aminopropanol derivatives |
| 05/31/2006 | EP1660443A2 Cyclic amine bace-1 inhibitors having a benzamide substituent |
| 05/31/2006 | EP1660096A1 Cyclohexyl prostaglandin analogs as ep-4 -receptor agonists |